References
- Daniels G. Human blood groups. 3rd ed. Oxford: Blackwell Science, 2013.
- Roback JD, Combs MR, Grossman BJ, Hillyer CD. Technical manual: advancing transfusion and cellular therapies worldwide. Bethesda, MD: AABB, 2008.
- Lei YM, Nair L, Alegre ML. The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol 2015;39:9–19.
- Perry HE, Franklin RA, Bray SJ, Lo MK, Svensson LA, Henry SM. A novel study of association between Neisseria gonorrhoeae and the human carbohydrate blood groups. Immunohematology 2007;23:100–4.
- Wu AM, Wu JH, Singh T, Liu JH, Tsai MS, Gilboa-Garber N. Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. Biochimie 2006;88:1479–92.
- Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol 2015;159: 122-127.
- Santos CM, Pires MC, Leão TL, et al. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiology 2016;162:1195–207.
- Bouhnik Y, Raskine L, Simoneau G, et al. The capacity of non-digestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80:1658–64.
- Garro MS, Aguirre L, Giori GS. Biological activity of Bifidobacterium longum in response to environmental pH. Appl Microbiol Biotechnol 2005;70:612–7.
- Brasil. Ministério da Saúde. Portaria de Consolidação n. 5, de 28 de setembro de 2017. Brasília: Ministério da Saúde, 2017.
- Girello AL, Kühn TIBB. Fundamentos da imunohema-tologiaeritrocitária. 4th ed. São Paulo, SP: Senac, 2014.
- Judd WJ, Johnson ST, Storry JR. Judd’s methods in immunohematology. 3rd ed. Bethesda, MD: AABB Press, 2008:557–9.
- Scardovi V. Genus Bifidobacterium. In: Bergey’s manual of systematic bacteriology. Baltimore, MD: Williams and Wilkins, 1986:1418–34.
- Orban JI, Patterson JA. Modification of the phosphoketolase assay for rapid identification of bifidobacterias. J Microbiol Methods 2000;40:221–4.
- Vinderola CG, Reinheimer JA. Enumeration of Lactobacillus casei in the presence of Lactobacillus acidophilus and lactic starter in fermented dairy products. Int. Dairy J 2000;10: 271–5.
- Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G. Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab 2019;74:115–24.
- Check JH, O’Neill EA, O’Neill KE, Fuscaldo KE. Effect of anti-B antiserum on the phagocytosis of Escherichia coli. Infect Immun 1972;6:95–6.
- Garratty, G. Blood groups and disease: a historical perspective. Transfus Med Rev 2012;14:291–301.
- Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012;26: 103–18.
- Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med 2016;8:517–535.
- Gampa A, Engen PA, Shobar R, Mutlu EA. Relationships between gastrointestinal microbiota and blood group antigens. Physiol Genomics 2017;49:473–83.
- Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.
- Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012;52:2087–93.
- Mäkivuokko H, Lahtinen SJ, Wacklin P, et al. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol 2012;6:12–94.
- Davenport ER, Goodrich JK, Bell JT, Spector TD, Ley RE, Clark AG. ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins. BMC Genomics 2016;17:941.
- Springer GF, Williamson P, Brandes WC. Blood group activity of Gram-negative bacteria. J Exp Med 1961;113:1077–93.
- Schenkel-Brunner H. Human blood groups. Chemical and biochemical basis of antigen specificity. 2nd ed. New York: Springer, 2000.
- Yamamoto F. Review: ABO blood group system—ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 2004;20:3–22.
- Gomes NM, de Souza NB, Cruz, AB, Valcarenghi D, Geraldo A. Ação bactericida de isoaglutininas ABO em diferentes diluições de anticorpos anti-ABO. Revista de Biotecnologia & Ciência. 2021;10:38–53.
- Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009;25:48–59.
- Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clin Chim Acta 2015;444:66–71.
- Mukherjee AP. Hypothesis: Immunotherapy by selective convalescent blood engineering to stifle diseases like COVID-19. Int J Med Sci 2021;18:3389–94.
- Stowell SR, Arthur CM, Dias-Baruffi M, et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 2010;16:295–301.
- Ewald DR, Sumner SCJ. Human microbiota, blood group antigens, and disease. Wiley Interdiscip Rev Syst Biol Med 201;10:e1413.
- Uchida H, Kinoshita H, Kawai Y, et al. Lactobacilli binding human A-antigen expressed in intestinal mucosa. Res Microbiol 2006;157:659–65.
- WHO – World Health Organization Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO): Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk and live lactic bacteria. Available from: https://www.fao.org/publications/card/fr/c/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/2006. Accessed 28 June 2022.
- Milajerdi A, Mousavi SM, Sadeghi A, et al. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr 2020;59:633–49.
- Tesser HC, Bueno EC, Nesello AN, Geraldo A. Avaliação do consumo e percepção dos efeitos dos probióticos por universitários com diferentes fenótipos ABO. R Bras Tecnol Agroindustr 2020;14:3418–34.
- Czerwiński M. Grupy. [Blood groups – minuses and pluses. Do the blood group antigens protect us from infectious diseases?] [in Polish]. Postepy Hig Med Dosw 2015;25:703–22.
- Gilmiyarova FN, Kolotyeva NA, Kuzmicheva VI, et al. [Blood group and human diseases (review of literature)]. [in Russian]. Klin Lab Diagn 2020;65:216–21.
- Bailey JD, Fisher AD, Yazer MH, et al. Changes in donor antibody titer levels over time in a military group O low-titer whole blood program. Transfusion 2019;59(S2):1499–506.
- Koch EJ, Snow R, Cook JT, Wickman D, Lee J, Zarow GJ. Variation of anti-A and anti-B titers in group O potential blood donors: a pilot study. J Trauma Acute Care Surg 2021;1;91(2S Suppl 2):221–5.